Vaughn Ostland, Ph.D.
Vaughn Ostland PhD has served as Chief Operations Officer since March 2009. Dr. Ostland is a founding member and is responsible for a wide range of management, R&D and manufacturing duties. He has been instrumental in establishing and implementing core business, scientific and manufacturing operations, including Information Technology infrastructure, maintaining regulatory compliance and managing Intrinsic’s patent portfolio. Dr. Ostland serves as PI of Intrinsic’s NIH-sponsored R&D program, directs Intrinsic’s product pipeline including overseeing all manufacturing practices. He has over 60 peer-reviewed scientific publications, holds a M.Sc. in Comparative Veterinary Pathology and a Ph.D. in Pathobiology from the University of Guelph and recently joined the Supervisory Board of the International Clinical Research Center at St. Anne’s University Hospital, in Brno, Czech Republic.
Vaughn Ostland’s Selected Publications:
- • Iron-deficiency anemia in Castleman disease: implication of the interleukin 6/hepcidin pathway
- • Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis
- • Maternal serum hepcidin is low at term and independent of cord blood iron status
- • Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections
- • Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge
For the full list of publications, click here http://www.ncbi.nlm.nih.gov/pubmed?term=Ostland%20v